Clinical TrialsBioMarin Sees Biomarker Win Fade Against Clinical Reality in ENERGY 3 Trial BioMarin Sees Biomarker Win Fade Against Clinical Reality in ENERGY 3 Trial Read Post »
Health Tidings Mergers & AcquisitionsBioMarin Bolsters Its Rare Disease Portfolio Through Amicus Acquisition BioMarin Bolsters Its Rare Disease Portfolio Through Amicus Acquisition Read Post »
